29 related articles for article (PubMed ID: 15017130)
1. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
[TBL] [Abstract][Full Text] [Related]
2. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.
Taylor DH; Østbye T; Langa KM; Weir D; Plassman BL
J Alzheimers Dis; 2009; 17(4):807-15. PubMed ID: 19542620
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry for Diagnosing Melanoma in Older Adults.
Ojukwu K; Eguchi MM; Adamson AS; Kerr KF; Piepkorn MW; Murdoch S; Barnhill RL; Elder DE; Knezevich SR; Elmore JG
JAMA Dermatol; 2024 Apr; 160(4):434-440. PubMed ID: 38446470
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data.
Ma Q; Shilkrut M; Zhao Z; Li M; Batty N; Barber B
BMC Cancer; 2018 Feb; 18(1):145. PubMed ID: 29409500
[TBL] [Abstract][Full Text] [Related]
6. Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study.
Orso M; Serraino D; Abraha I; Fusco M; Giovannini G; Casucci P; Cozzolino F; Granata A; Gobbato M; Stracci F; Ciullo V; Vitale MF; Eusebi P; Orlandi W; Montedori A; Bidoli E;
BMJ Open; 2018 Apr; 8(4):e020631. PubMed ID: 29678984
[TBL] [Abstract][Full Text] [Related]
7. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
8. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of family cancer history reported in a population-based survey.
Mai PL; Garceau AO; Graubard BI; Dunn M; McNeel TS; Gonsalves L; Gail MH; Greene MH; Willis GB; Wideroff L
J Natl Cancer Inst; 2011 May; 103(10):788-97. PubMed ID: 21562245
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic status and chemotherapy use for melanoma in older people.
Reyes-Ortiz CA; Goodwin JS; Zhang DD; Freeman JL
Can J Aging; 2011 Mar; 30(1):143-53. PubMed ID: 21356154
[TBL] [Abstract][Full Text] [Related]
11. Development of query strategies to identify a histologic lymphoma subtype in a large linked database system.
Graiser M; Moore SG; Victor R; Hilliard A; Hill L; Keehan MS; Flowers CR
Cancer Inform; 2007 May; 3():149-58. PubMed ID: 19455241
[TBL] [Abstract][Full Text] [Related]
12. Health state information derived from secondary databases is affected by multiple sources of bias.
Terris DD; Litaker DG; Koroukian SM
J Clin Epidemiol; 2007 Jul; 60(7):734-41. PubMed ID: 17573990
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status and survival in older patients with melanoma.
Reyes-Ortiz CA; Goodwin JS; Freeman JL; Kuo YF
J Am Geriatr Soc; 2006 Nov; 54(11):1758-64. PubMed ID: 17087705
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States).
Barzilai DA; Koroukian SM; Neuhauser D; Cooper KD; Rimm AA; Cooper GS
Cancer Causes Control; 2004 Mar; 15(2):179-84. PubMed ID: 15017130
[TBL] [Abstract][Full Text] [Related]
15. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
16. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
18. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
19. Administrative and claims records as sources of health care cost data.
Riley GF
Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
